GlassScriptPhysician profile
Megan Danyel Johnson
NPI 1780027607
$854.69
in general payments reported to CMS, 2019-2025
20 companies · $29.58 in 2025
The $29.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2021: $84.43 · 2025: $29.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $129.81 | 2019 | |
| Nuvasive, INC. | $84.43 | 2021 | |
| Amgen INC. | $79.69 | 2019 | |
| Pfizer INC. | $66.74 | 2019 | |
| Glaxosmithkline, LLC. | $57.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $52.48 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.59 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.92 | 2019 | |
| Astellas Pharma US INC | $42.20 | 2019 | |
| Lilly USA, LLC | $36.30 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.77 | 2019 | |
| Shire North American Group INC | $32.33 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $29.58 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $26.97 | 2019 | |
| Abbott Laboratories | $22.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.18 | 2019 | |
| Abbvie INC. | $14.83 | 2019 | |
| Amarin Pharma, INC. | $14.23 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $11.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.